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Figure S3. HPLC profiles of the crude extracts of M. sulfurea cultured in PDA 
containing 0.5% KCl, KBr, and KI, respectively 
 
 
Figure S4. The HPLC profiles of malbranpyrroles from M. sulfurea incubated in PDA 
containing 1% amino acids
S5
 
Table S1. 13C NMR chemical shifts (125 MHz, in d6-acetone) and enrichment ratios 
of malbranpyrrole F (6), isolated after feeding of [1-13C]acetate, [2-13C]acetate, 
[13C2]acetate, and [2-13C]glycerol 
 [1-13C]acetate [2-13C]acetate [13C2]acetate [2-13C]glycerol
carbon ppm enrichment (%) enrichment (%) 2J to C (Hz) enrichment (%)
2 121.5 4.7 0.5 32.4 0.3
3 110.7 -1.0 14.1 32.4 -1.0
4 114.8 -3.0 6.8  b - -1.0
5 127.6 -2.0 6.9 34.4 -2.0
6 124.9 13.3 2.5 34.4 9.0
7 121.2 0.4 11.7 29.8 -1.0
8 133.3 19.6 a 0 29.8 10.3
9 126.2 0.3 8.4 32.8 -1.0
10 164.6 8.8 -1.0 32.8 11.1
11 93.9 a 0 5.4 33.5 -2.0
12 170.2 9.8 -3.0 33.5 12.3
13 109.5 1.2 13.6 42.9 4.4
14 160.4 13.6 0.6 42.9 3.9
15 12.8 -2.0 -2.0 b - 3.2
18 14.9 16.9 -1.0 19.9 11.7
17 92.6 0.5 4.4 19.9 0.2
16 43.7 15.6 -2.0 18.0 9.7
20 20.5 0.9 10.1 18.0 a 0.5
19 25.8 -3.0 11.2  c 18.0 a 0.2
a standard carbon for enrichment ratio calculation; b singlet signal; c the enrichment 





 Table S2. Cytotoxicity (μM) of malbarnpyrroles C-F (3-6) withouta/withb UV 
irradiation 
 PANC-1a PANC-1b HepG2a HepG2b MCF-7a MCF-7b 
C 11 7.0 4.6 2.8 7.1 6.3 
D 6.3 7.2 7.7 7.3 8.9 5.8 
E 4.5 7.4 5.3 0.7 8.4 5.6 
F 3.3 7.8 7.1 7.3 7.7 4.8 
Doxorubicin 4.0 - 1.6 - 2.8 - 
 
Table S3. Cell cycle analysis of malbranpyrroles C-F (3-6) in MCF-7 and HepG2  
  MCF-7 HepG2 
 Conc. (μM) G0/G1 S G2/M G0/G1 S G2/M 
Control  47.2 34.6 17.3 63.4 12.0 24.6 
F   1    53.7 29.3 17.0 65.0 14.4 20.7 
 10    62.8 20.9 16.3 72.0 7.0 21.1 
 25    60.5 20.5 19.0 69.4 8.3 22.3 
D   1    53.7 33.3 13.1 62.6 16.1 21.4 
 10    61.8 22.2 16.0 77.2 0.3 22.6 
 25    62.1 20.1 17.8 70.9 6.0 23.1 
E   1    55.9 28.7 15.4 65.9 12.0 22.1 
 10    70.7 16.4 13.0 69.7 9.0 21.3 
 25    62.5 20.0 17.5 67.8 2.6 29.6 
C   1    56.5 29.3 14.2 66.3 12.0 21.7 
 10    65.1 17.5 17.5 68.9 7.9 31.1 
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SS5. 13C NMR (125 MHz, d6-acetone) spectra of malbranpyrroles A (1) and C-F (3-6) 
 




SS7. 1H-1H COSY spectrum of malbranpyrrole A (1) 
  




SS9. NOESY spectrum of malbranpyrrole A (1) 
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SS10. 1H-1H COSY spectrum (deduced from LC-SPE-NMR) of malbranpyrrole B (2) 
 
SS11. HSQC spectrum (deduced from LC-SPE-NMR) of malbranpyrrole B (2) 
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SS12. Superposition of HSQC (red) and HMBC (black) spectra of malbranpyrrole C 
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SS13. NOESY spectrum of malbranpyrrole C (3) 
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SS14. 1H-1H COSY spectrum of malbranpyrrole D (4) 
 




SS16. NOESY spectrum of malbranpyrrole D (4) 
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SS17. 1H-1H COSY spectrum of malbranpyrrole E (5) 
 




SS19. NOESY spectrum of malbranpyrrole E (6) 
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SS20. 1H-1H COSY spectrum of malbranpyrrole F (6) 
 




SS22. NOESY spectrum of malbranpyrrole F (6) 
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